YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy

The transcriptional co‐activators YAP (or YAP1) and TAZ (or WWTR1) are frequently activated during the growth and progression of many solid tumors, including lung, colorectal, breast, pancreatic, and liver carcinomas as well as melanoma and glioma. YAP/TAZ bind to TEAD‐family co‐activators to drive...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BioEssays Ročník 42; číslo 5; s. e1900162 - n/a
Hlavní autor: Thompson, Barry J.
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States Wiley Subscription Services, Inc 01.05.2020
Témata:
ISSN:0265-9247, 1521-1878, 1521-1878
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract The transcriptional co‐activators YAP (or YAP1) and TAZ (or WWTR1) are frequently activated during the growth and progression of many solid tumors, including lung, colorectal, breast, pancreatic, and liver carcinomas as well as melanoma and glioma. YAP/TAZ bind to TEAD‐family co‐activators to drive cancer cell survival, proliferation, invasive migration, and metastasis. YAP/TAZ activation may also confer resistance to chemotherapy, radiotherapy, or immunotherapy. YAP‐TEAD cooperates with the RAS‐induced AP‐1 (FOS/JUN) transcription factor to drive tumor growth and cooperates with MRTF‐SRF to promote activation of cancer‐associated fibroblasts, matrix stiffening, and metastasis. The key upstream repressor of YAP/TAZ activation is the Hippo (MST1/2‐LATS1/2) pathway and the key upstream activators are mechanically induced Integrin‐SRC and E‐cadherin‐AJUBA/TRIP6/LIMD1, growth factor induced PI3K‐AKT, and inflammation‐induced G‐protein coupled receptor (GPCR) signals, all of which antagonize the Hippo pathway. In this review, strategies to target YAP/TAZ activity in cancer are discussed along with the prospects for synergy with established pillars of cancer therapy. YAP and TAZ are key mediators of wound healing and tissue regeneration responses as well as important drivers of solid tumor growth, metastasis, and resistance to therapy, making them attractive therapeutic targets for cancer.
AbstractList The transcriptional co‐activators YAP (or YAP1) and TAZ (or WWTR1) are frequently activated during the growth and progression of many solid tumors, including lung, colorectal, breast, pancreatic, and liver carcinomas as well as melanoma and glioma. YAP/TAZ bind to TEAD‐family co‐activators to drive cancer cell survival, proliferation, invasive migration, and metastasis. YAP/TAZ activation may also confer resistance to chemotherapy, radiotherapy, or immunotherapy. YAP‐TEAD cooperates with the RAS‐induced AP‐1 (FOS/JUN) transcription factor to drive tumor growth and cooperates with MRTF‐SRF to promote activation of cancer‐associated fibroblasts, matrix stiffening, and metastasis. The key upstream repressor of YAP/TAZ activation is the Hippo (MST1/2‐LATS1/2) pathway and the key upstream activators are mechanically induced Integrin‐SRC and E‐cadherin‐AJUBA/TRIP6/LIMD1, growth factor induced PI3K‐AKT, and inflammation‐induced G‐protein coupled receptor (GPCR) signals, all of which antagonize the Hippo pathway. In this review, strategies to target YAP/TAZ activity in cancer are discussed along with the prospects for synergy with established pillars of cancer therapy.
The transcriptional co-activators YAP (or YAP1) and TAZ (or WWTR1) are frequently activated during the growth and progression of many solid tumors, including lung, colorectal, breast, pancreatic, and liver carcinomas as well as melanoma and glioma. YAP/TAZ bind to TEAD-family co-activators to drive cancer cell survival, proliferation, invasive migration, and metastasis. YAP/TAZ activation may also confer resistance to chemotherapy, radiotherapy, or immunotherapy. YAP-TEAD cooperates with the RAS-induced AP-1 (FOS/JUN) transcription factor to drive tumor growth and cooperates with MRTF-SRF to promote activation of cancer-associated fibroblasts, matrix stiffening, and metastasis. The key upstream repressor of YAP/TAZ activation is the Hippo (MST1/2-LATS1/2) pathway and the key upstream activators are mechanically induced Integrin-SRC and E-cadherin-AJUBA/TRIP6/LIMD1, growth factor induced PI3K-AKT, and inflammation-induced G-protein coupled receptor (GPCR) signals, all of which antagonize the Hippo pathway. In this review, strategies to target YAP/TAZ activity in cancer are discussed along with the prospects for synergy with established pillars of cancer therapy.The transcriptional co-activators YAP (or YAP1) and TAZ (or WWTR1) are frequently activated during the growth and progression of many solid tumors, including lung, colorectal, breast, pancreatic, and liver carcinomas as well as melanoma and glioma. YAP/TAZ bind to TEAD-family co-activators to drive cancer cell survival, proliferation, invasive migration, and metastasis. YAP/TAZ activation may also confer resistance to chemotherapy, radiotherapy, or immunotherapy. YAP-TEAD cooperates with the RAS-induced AP-1 (FOS/JUN) transcription factor to drive tumor growth and cooperates with MRTF-SRF to promote activation of cancer-associated fibroblasts, matrix stiffening, and metastasis. The key upstream repressor of YAP/TAZ activation is the Hippo (MST1/2-LATS1/2) pathway and the key upstream activators are mechanically induced Integrin-SRC and E-cadherin-AJUBA/TRIP6/LIMD1, growth factor induced PI3K-AKT, and inflammation-induced G-protein coupled receptor (GPCR) signals, all of which antagonize the Hippo pathway. In this review, strategies to target YAP/TAZ activity in cancer are discussed along with the prospects for synergy with established pillars of cancer therapy.
The transcriptional co‐activators YAP (or YAP1) and TAZ (or WWTR1) are frequently activated during the growth and progression of many solid tumors, including lung, colorectal, breast, pancreatic, and liver carcinomas as well as melanoma and glioma. YAP/TAZ bind to TEAD‐family co‐activators to drive cancer cell survival, proliferation, invasive migration, and metastasis. YAP/TAZ activation may also confer resistance to chemotherapy, radiotherapy, or immunotherapy. YAP‐TEAD cooperates with the RAS‐induced AP‐1 (FOS/JUN) transcription factor to drive tumor growth and cooperates with MRTF‐SRF to promote activation of cancer‐associated fibroblasts, matrix stiffening, and metastasis. The key upstream repressor of YAP/TAZ activation is the Hippo (MST1/2‐LATS1/2) pathway and the key upstream activators are mechanically induced Integrin‐SRC and E‐cadherin‐AJUBA/TRIP6/LIMD1, growth factor induced PI3K‐AKT, and inflammation‐induced G‐protein coupled receptor (GPCR) signals, all of which antagonize the Hippo pathway. In this review, strategies to target YAP/TAZ activity in cancer are discussed along with the prospects for synergy with established pillars of cancer therapy. YAP and TAZ are key mediators of wound healing and tissue regeneration responses as well as important drivers of solid tumor growth, metastasis, and resistance to therapy, making them attractive therapeutic targets for cancer.
Author Thompson, Barry J.
Author_xml – sequence: 1
  givenname: Barry J.
  orcidid: 0000-0002-0103-040X
  surname: Thompson
  fullname: Thompson, Barry J.
  email: Barry.Thompson@anu.edu.au
  organization: The Australian National University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32128850$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1rFEEQhhuJmE306lEavHjIbLpr-mPa2xqTTSCi6HrQS9PTU0M6zE6v3TOG_ffOsolCQAIFVYfnKah6j8hBH3sk5DVnc84YnNYB8xwYN4xxBc_IjEvgBa90dUBmDJQsDAh9SI5yvmWMGQXiBTksgUNVSTYjyx-LL6erxc_39GMKvzFlGlu6Gtcx0WWKd8PNCf2Eg8tThXxCXd_QrziNg-s90iHS1Q0mt9m-JM9b12V8dd-PyfeL89XZZXH9eXl1trguvOQABbIGG9FohBqVdLotJZRCO6GQe9OWAK0xrfdKTueoVrFaeK-lUQYV1IDlMXm337tJ8deIebDrkD12nesxjtmCBAFcl1o-jZaac1Gaaoe-fYTexjH10yETZZjQxjCYqDf31FivsbGbFNYube3DNydA7AGfYs4JW-vD4IYQ-yG50FnO7C40uwvN_g1t0uaPtIfN_xXMXrgLHW6foO2Hq_Nv_9w_Gi2mOQ
CitedBy_id crossref_primary_10_1016_j_intimp_2023_110586
crossref_primary_10_1007_s10238_021_00738_4
crossref_primary_10_1042_BST20200506
crossref_primary_10_1126_science_adp2974
crossref_primary_10_1038_s41568_023_00579_1
crossref_primary_10_1016_j_biopha_2021_111824
crossref_primary_10_3389_fonc_2021_632956
crossref_primary_10_1155_2021_5212721
crossref_primary_10_1016_j_lfs_2020_118662
crossref_primary_10_1371_journal_pone_0325535
crossref_primary_10_1007_s10565_024_09956_4
crossref_primary_10_2174_0113892002351556250123105344
crossref_primary_10_1016_j_bbadis_2023_166884
crossref_primary_10_1038_s41467_024_49045_y
crossref_primary_10_1038_s41467_024_52888_0
crossref_primary_10_3390_cancers14215343
crossref_primary_10_15252_embj_2022112184
crossref_primary_10_1080_01652176_2021_1923085
crossref_primary_10_1186_s12885_023_11637_0
crossref_primary_10_1002_ptr_8268
crossref_primary_10_3389_fcell_2025_1522705
crossref_primary_10_7554_eLife_98386_3
crossref_primary_10_1038_s41419_020_03054_z
crossref_primary_10_1186_s13046_025_03350_6
crossref_primary_10_1007_s10549_023_07138_0
crossref_primary_10_3390_ijms23010430
crossref_primary_10_1111_cpr_12887
crossref_primary_10_3390_bios14120570
crossref_primary_10_3390_cancers15194701
crossref_primary_10_1038_s41420_022_01204_0
crossref_primary_10_3390_cancers17020255
crossref_primary_10_3390_cancers15204956
crossref_primary_10_1016_j_prp_2021_153720
crossref_primary_10_15252_embj_2023114558
crossref_primary_10_1177_03000605231182557
crossref_primary_10_1111_febs_16926
crossref_primary_10_1007_s11060_021_03699_6
crossref_primary_10_15252_embj_2022112863
crossref_primary_10_2147_OTT_S253691
crossref_primary_10_1155_2022_5942379
crossref_primary_10_1007_s00011_021_01494_7
crossref_primary_10_3390_ijms222212426
crossref_primary_10_1007_s12672_021_00408_7
crossref_primary_10_1093_carcin_bgad026
crossref_primary_10_3390_cancers13184650
crossref_primary_10_1016_j_yexcr_2022_113404
crossref_primary_10_1016_j_tibs_2022_12_005
crossref_primary_10_3389_fonc_2022_976557
crossref_primary_10_1016_j_ceca_2022_102539
crossref_primary_10_1111_acel_13288
crossref_primary_10_1038_s44319_025_00514_5
crossref_primary_10_1159_000539928
crossref_primary_10_1002_gch2_202100094
crossref_primary_10_1186_s12935_022_02623_w
crossref_primary_10_5812_ijcm_156834
crossref_primary_10_1016_j_yexcr_2023_113585
crossref_primary_10_1186_s12885_024_12316_4
crossref_primary_10_3389_fonc_2020_612802
crossref_primary_10_1016_j_canlet_2021_03_006
crossref_primary_10_1038_s41388_022_02198_w
crossref_primary_10_1038_s41467_024_49230_z
crossref_primary_10_7554_eLife_98386
crossref_primary_10_1515_biol_2021_0039
crossref_primary_10_15252_embj_2021108719
crossref_primary_10_3892_ijo_2024_5656
crossref_primary_10_1002_path_6395
crossref_primary_10_1098_rsob_210335
crossref_primary_10_1186_s12935_021_01999_5
crossref_primary_10_3390_cells10082080
crossref_primary_10_1186_s12943_024_01953_9
crossref_primary_10_1016_j_bcp_2021_114423
crossref_primary_10_1186_s10020_025_01169_7
crossref_primary_10_3390_ijms25074064
crossref_primary_10_3390_medicina61061112
crossref_primary_10_3390_cancers12061361
crossref_primary_10_3390_cancers13205126
crossref_primary_10_1093_nar_gkad107
crossref_primary_10_1002_tox_24122
crossref_primary_10_3390_biology11040585
crossref_primary_10_1016_j_canlet_2025_217846
crossref_primary_10_1007_s13402_023_00910_w
crossref_primary_10_3390_cancers15020429
crossref_primary_10_3390_cells11091467
crossref_primary_10_1038_s41419_023_06157_5
crossref_primary_10_3390_jcm11102852
crossref_primary_10_1016_j_biopha_2022_113757
crossref_primary_10_1016_j_tcb_2022_01_013
crossref_primary_10_13005_bpj_2250
crossref_primary_10_1016_j_jsbmb_2025_106693
crossref_primary_10_1038_s41419_022_05147_3
crossref_primary_10_3389_fmolb_2024_1423795
crossref_primary_10_1038_s41420_025_02493_x
crossref_primary_10_1016_j_mam_2025_101358
crossref_primary_10_3389_fcell_2021_743722
crossref_primary_10_3390_cancers16162861
crossref_primary_10_1038_s41419_021_04423_y
crossref_primary_10_3390_cancers14246178
crossref_primary_10_1002_tox_23363
crossref_primary_10_1016_j_biopha_2023_114462
crossref_primary_10_1093_carcin_bgac081
crossref_primary_10_1186_s12575_025_00282_5
crossref_primary_10_1038_s41388_023_02926_w
crossref_primary_10_3390_cancers13174264
crossref_primary_10_1007_s13258_023_01461_y
crossref_primary_10_26508_lsa_202201445
crossref_primary_10_3389_fimmu_2024_1377722
crossref_primary_10_1186_s12935_025_03946_0
crossref_primary_10_1096_fj_202201181R
crossref_primary_10_3389_fonc_2021_772134
crossref_primary_10_1016_j_ydbio_2020_12_018
crossref_primary_10_1515_biol_2022_0743
crossref_primary_10_1016_j_bbcan_2023_188892
crossref_primary_10_1016_j_heliyon_2024_e38452
crossref_primary_10_1016_j_plrev_2023_01_017
crossref_primary_10_1038_s41417_024_00761_z
crossref_primary_10_3390_ijms241310910
crossref_primary_10_3390_cancers13123100
crossref_primary_10_1111_exd_14272
crossref_primary_10_1042_BST20200253
crossref_primary_10_1016_j_currproblcancer_2024_101152
crossref_primary_10_1016_j_prp_2022_154231
crossref_primary_10_1016_j_prp_2024_155286
crossref_primary_10_1111_jcmm_17860
crossref_primary_10_1002_jcla_24066
crossref_primary_10_1016_j_expneurol_2024_114864
crossref_primary_10_15252_embj_2020105770
crossref_primary_10_1016_j_yexcr_2021_112613
crossref_primary_10_1111_wrr_12889
crossref_primary_10_1615_CritRevImmunol_2025057246
crossref_primary_10_1093_neuonc_noab016
crossref_primary_10_1080_01478885_2020_1847012
crossref_primary_10_3390_cancers16050852
crossref_primary_10_1007_s00432_023_05272_2
crossref_primary_10_1007_s11523_022_00900_2
crossref_primary_10_1002_tox_23341
crossref_primary_10_1155_2022_5351611
crossref_primary_10_1186_s12958_022_00909_2
crossref_primary_10_3892_ol_2022_13226
crossref_primary_10_1038_s41401_024_01231_w
crossref_primary_10_1080_13543784_2024_2432395
crossref_primary_10_1038_s42003_025_08160_2
crossref_primary_10_1016_j_molimm_2024_04_001
crossref_primary_10_1155_2020_4892938
crossref_primary_10_1007_s12672_025_02573_5
crossref_primary_10_3390_jcm11154560
crossref_primary_10_1016_j_lfs_2025_123483
crossref_primary_10_3390_cancers14133102
crossref_primary_10_1111_nan_12762
crossref_primary_10_3390_cancers14205050
crossref_primary_10_1111_cas_15390
crossref_primary_10_1007_s00018_024_05296_y
crossref_primary_10_1016_j_bbrc_2023_05_101
crossref_primary_10_3389_fonc_2023_1213426
crossref_primary_10_3390_ijms23031855
crossref_primary_10_1002_mco2_70281
crossref_primary_10_1111_cup_13832
crossref_primary_10_3390_jcm11164765
crossref_primary_10_1016_j_dld_2023_05_014
crossref_primary_10_1186_s12929_024_01049_y
crossref_primary_10_1371_journal_pone_0275679
crossref_primary_10_1111_exd_14655
crossref_primary_10_1186_s13046_022_02472_5
crossref_primary_10_1016_j_abb_2025_110305
crossref_primary_10_1016_j_biochi_2024_03_008
crossref_primary_10_1096_fj_202001063R
crossref_primary_10_3390_medicina57090860
crossref_primary_10_3390_diagnostics12030656
crossref_primary_10_1016_j_bbrc_2023_04_033
crossref_primary_10_1158_0008_5472_CAN_22_3003
crossref_primary_10_3390_cancers12113147
crossref_primary_10_1038_s41388_025_03477_y
crossref_primary_10_3390_cancers15123147
crossref_primary_10_1038_s41598_024_63613_8
crossref_primary_10_3389_fcell_2025_1610471
Cites_doi 10.18632/oncotarget.22392
10.1126/stke.3922007pe35
10.1038/ncb1833
10.1128/MCB.00772-15
10.1158/0008-5472.CAN-17-2464
10.1016/j.cell.2006.07.013
10.1038/nature12930
10.1158/1541-7786.MCR-14-0580
10.1093/neuonc/nox036.039
10.1016/j.ccell.2019.05.003
10.1016/j.celrep.2018.10.001
10.18632/oncotarget.4043
10.1016/j.cub.2006.08.057
10.1016/j.cub.2012.02.050
10.1158/0008-5472.CAN-10-1242
10.1371/journal.pgen.1004994
10.1016/j.freeradbiomed.2017.12.005
10.1158/0008-5472.CAN-17-0391
10.1016/0092-8674(88)90244-9
10.1186/s13046-018-0892-2
10.1074/jbc.RA118.004364
10.1038/srep16759
10.1016/j.cell.2006.05.030
10.1101/gad.274951.115
10.1073/pnas.1212021109
10.1158/0008-5472.CAN-17-3139
10.1038/nature14228
10.3892/or.2014.3305
10.1158/1078-0432.CCR-15-0226
10.1016/j.devcel.2010.06.015
10.1074/jbc.M203130200
10.1016/j.yexcr.2016.11.024
10.1038/emm.2017.205
10.1016/S0092-8674(00)00122-7
10.1083/jcb.201609037
10.1093/jnci/djx014
10.1016/j.celrep.2018.08.061
10.1371/journal.pone.0109575
10.1038/oncsis.2013.12
10.1016/j.cell.2007.04.019
10.1016/j.cub.2016.06.035
10.18632/oncotarget.22865
10.1002/gcc.22073
10.1158/0008-5472.CAN-07-2696
10.1016/j.ccell.2019.01.009
10.3892/mmr.2015.4550
10.1016/S0959-8049(16)61627-1
10.1038/ncomms9126
10.18632/oncotarget.5971
10.1016/j.ceb.2017.12.003
10.1016/j.cell.2015.07.013
10.1016/j.devcel.2019.03.026
10.1242/dev.070987
10.2147/OTT.S102733
10.1007/s12020-017-1240-6
10.1091/mbc.6.10.1349
10.1073/pnas.1313192110
10.1242/jcs.039446
10.1002/path.4922
10.1016/j.cell.2014.06.004
10.1101/gad.1978810
10.1038/onc.2012.53
10.7150/thno.23964
10.1158/1541-7786.MCR-17-0593
10.1128/MCB.24.19.8586-8599.2004
10.1128/MCB.01874-07
10.7150/jca.16438
10.1371/journal.pone.0065539
10.1038/bjc.2017.259
10.1073/pnas.1704030114
10.1158/1541-7786.MCR-17-0023
10.7150/ijms.23460
10.1093/carcin/bgn200
10.1056/NEJMra1704560
10.1126/science.aav0173
10.1073/pnas.93.16.8425
10.1242/jcs.001586
10.4161/cam.5.4.17290
10.1016/j.devcel.2010.09.009
10.1172/JCI95802
10.15252/embr.201744777
10.1016/j.cell.2011.02.031
10.1097/PAI.0000000000000344
10.1083/jcb.113.4.867
10.1074/jbc.M110.119909
10.1038/onc.2011.8
10.1016/j.devcel.2008.01.006
10.3892/ijo.2015.2948
10.1016/j.devcel.2004.05.020
10.1016/j.devcel.2019.04.014
10.1083/jcb.200708174
10.1158/0008-5472.CAN-10-0738
10.1101/gad.1664408
10.1371/journal.pgen.1001140
10.18632/oncotarget.23638
10.1016/j.bbrc.2019.05.143
10.1074/jbc.274.3.1185
10.1073/pnas.0912203107
10.1007/s12094-015-1353-4
10.15252/embj.201695137
10.1186/1471-213X-11-57
10.1101/gad.1758709
10.1016/S0092-8674(00)81011-9
10.1002/jcb.26388
10.1073/pnas.0911427107
10.1083/jcb.201210073
10.1074/jbc.272.7.4637
10.18632/oncotarget.3546
10.1101/gad.888601
10.1042/BCJ20180225
10.1016/j.ejca.2018.05.013
10.18632/oncotarget.14319
10.18632/oncotarget.15677
10.1242/dmm.026500
10.18632/oncotarget.15614
10.1158/1541-7786.MCR-18-0407
10.1016/S0092-8674(05)80020-0
10.1073/pnas.1112499109
10.1126/scisignal.2005049
10.1038/nature15382
10.7554/eLife.31037
10.1083/jcb.135.6.1633
10.1053/j.gastro.2016.11.005
10.1101/gad.192856.112
10.1016/j.celrep.2017.10.078
10.1016/j.ccr.2014.05.029
10.1016/j.scr.2018.03.005
10.1016/j.cell.2012.11.026
10.1016/j.immuni.2012.03.013
10.1016/j.jid.2016.10.029
10.1074/jbc.275.17.12619
10.1101/gad.237743.114
10.1172/JCI93825
10.1038/ncb3073
10.1093/carcin/bgq254
10.1038/onc.2014.5
10.1016/j.tcb.2006.09.008
10.18632/oncotarget.5772
10.1128/MCB.01623-07
10.1186/s13046-018-0740-4
10.1038/onc.2014.206
10.1038/s41375-018-0111-3
10.1126/science.283.5402.655
10.1016/j.cell.2017.07.029
10.1101/gad.1726608
10.1016/j.cell.2014.05.035
10.1016/j.semcdb.2012.06.001
10.1016/j.cell.2012.06.037
10.1073/pnas.0605579103
10.1038/npjbcancer.2016.17
10.1074/jbc.RA118.005457
10.1073/pnas.1620290114
10.1182/blood-2014-01-453134
10.1016/j.ajpath.2017.12.017
10.1074/jbc.M116.739722
10.1073/pnas.1216462110
10.1038/s41419-018-0515-z
10.1128/MCB.00311-16
10.1016/j.coph.2008.06.012
10.1016/j.celrep.2016.07.020
10.1002/bies.201600037
10.1056/NEJMoa1000584
10.1002/j.1460-2075.1991.tb08027.x
10.1073/pnas.1610223114
10.1074/jbc.273.36.23110
10.1038/s41419-018-0302-x
10.3892/or.2017.5517
10.1126/science.8140422
10.1093/emboj/17.22.6622
10.1242/jcs.100115
10.1074/jbc.M507752200
10.1091/mbc.E06-12-1154
10.1016/j.celrep.2019.02.004
10.1101/gad.197582.112
10.1038/sj.onc.1204186
10.1016/j.mod.2014.07.001
10.1111/his.12697
10.1002/jcb.26246
10.1038/nrm2890
10.1038/onc.2016.288
10.3892/or.2017.5642
10.1177/039463201302600115
10.1042/CS20150385
10.1016/j.devcel.2013.04.021
10.1158/1541-7786.MCR-18-0158
10.1074/jbc.M113.529115
10.1083/jcb.201501025
10.1038/nm.2940
10.1002/hep.27992
10.1074/jbc.274.12.8335
10.1111/jcmm.13182
10.1038/ncomms14744
10.1016/j.ccr.2009.09.026
10.1016/j.ydbio.2012.05.008
10.1016/j.stem.2017.11.001
10.1038/sj.onc.1204192
10.1016/S0092-8674(03)00278-2
10.1158/0008-5472.CAN-15-2882
10.1681/ASN.2017121272
10.1016/j.str.2015.09.009
10.18632/oncotarget.8979
10.1038/jid.2012.430
10.1016/j.cell.2005.06.007
10.1126/science.aaa4559
10.1242/dev.159467
10.3390/cancers10040115
10.1158/0008-5472.CAN-14-3396
10.1128/MCB.25.14.5859-5868.2005
10.1002/embj.201386082
10.1016/j.cell.2014.06.003
10.1128/MCB.00102-15
10.1016/j.devcel.2008.01.007
10.1016/j.cell.2007.07.019
10.1101/gad.294348.116
10.1371/journal.pone.0091770
10.1016/j.celrep.2018.09.056
10.1038/onc.2015.219
10.1101/gad.233676.113
10.1073/pnas.0911409107
10.1016/j.cell.2017.10.008
10.1038/ncb2756
10.1073/pnas.1110428108
10.1016/j.cell.2015.10.044
10.1038/nature11693
10.1093/emboj/19.24.6778
10.1242/dev.102798
10.15252/emmm.201708699
10.1242/dev.045500
10.1091/mbc.E14-07-1223
10.1038/onc.2014.281
10.1073/pnas.222561499
10.1016/j.devcel.2017.08.013
10.1101/sqb.1998.63.643
10.1186/s13046-018-0962-5
10.1016/j.celrep.2019.03.091
10.1074/jbc.M302474200
10.1038/nrc969
10.1038/jid.2013.319
10.3892/ol.2016.4829
10.1016/j.oraloncology.2018.02.014
10.1053/j.gastro.2016.05.006
10.1073/pnas.1019603108
10.1074/jbc.M117.805655
10.1016/j.ceb.2017.10.006
10.1093/emboj/18.9.2551
10.3892/or.2015.4329
10.1172/JCI125014
10.1186/1471-2407-13-349
10.1074/jbc.M900843200
10.1073/pnas.1320383110
10.1093/emboj/17.21.6289
10.18632/oncotarget.12382
10.1101/gad.304501.117
10.1101/gad.1602907
10.1101/gad.264515.115
10.1091/mbc.e06-07-0602
10.1093/carcin/bgn278
10.1158/2326-6066.CIR-17-0320
10.1016/j.cub.2010.02.035
10.1186/1750-2187-2-2
10.1126/science.1141084
10.1038/ncb3216
10.1158/2159-8290.CD-15-0224
10.1038/s41388-018-0301-5
10.1242/dev.133728
10.1074/jbc.274.51.36734
10.3892/or.2014.3349
10.1074/jbc.M109101200
ContentType Journal Article
Copyright 2020 The Authors. published by Wiley Periodicals, Inc.
2020 The Authors. BioEssays published by Wiley Periodicals, Inc.
2020 WILEY Periodicals, Inc.
Copyright_xml – notice: 2020 The Authors. published by Wiley Periodicals, Inc.
– notice: 2020 The Authors. BioEssays published by Wiley Periodicals, Inc.
– notice: 2020 WILEY Periodicals, Inc.
DBID 24P
AAYXX
CITATION
NPM
7QL
7QO
7QP
7QR
7SS
7T7
7TK
7TM
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
7S9
L.6
DOI 10.1002/bies.201900162
DatabaseName Wiley Online Library Open Access (Activated by CARLI)
CrossRef
PubMed
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Entomology Abstracts (Full archive)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
PubMed
Virology and AIDS Abstracts
Technology Research Database
Nucleic Acids Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Entomology Abstracts
Genetics Abstracts
Biotechnology Research Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA
Virology and AIDS Abstracts
PubMed
MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1521-1878
EndPage n/a
ExternalDocumentID 32128850
10_1002_bies_201900162
BIES201900162
Genre article
Journal Article
GroupedDBID ---
-~X
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
23N
24P
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
85S
8UM
930
A03
AAESR
AAEVG
AAHBH
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEFU
ABEML
ABIJN
ABJNI
ABLJU
ABPVW
ABTAH
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACIWK
ACKIV
ACKOT
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BQCPF
BROTX
BRXPI
BY8
C45
CS3
D-E
D-F
D0L
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KD1
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M56
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MVM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RWR
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
UB1
UDS
V2E
W8V
W99
WBKPD
WH7
WIB
WIH
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WXSBR
WYB
WYISQ
XG1
XV2
Y6R
YYQ
YZZ
ZGI
ZUP
ZXP
ZY4
ZZTAW
~IA
~KM
~WT
AAMMB
AAYXX
AEFGJ
AETEA
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
CITATION
O8X
NPM
VXZ
7QL
7QO
7QP
7QR
7SS
7T7
7TK
7TM
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
7S9
L.6
ID FETCH-LOGICAL-c5122-e0ded4d7e2be65a7f352347a46e1c9f322f99fcc650166f60b4cc75969e62b2e3
IEDL.DBID 24P
ISICitedReferencesCount 201
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000528705900011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0265-9247
1521-1878
IngestDate Fri Jul 11 18:26:22 EDT 2025
Thu Oct 02 05:52:36 EDT 2025
Fri Jul 25 11:02:52 EDT 2025
Wed Feb 19 02:30:36 EST 2025
Sat Nov 29 05:24:45 EST 2025
Tue Nov 18 22:02:27 EST 2025
Wed Jan 22 16:34:04 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords cancer
tissue growth
Hippo pathway
YAP/TAZ
Language English
License Attribution
2020 The Authors. BioEssays published by Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5122-e0ded4d7e2be65a7f352347a46e1c9f322f99fcc650166f60b4cc75969e62b2e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-0103-040X
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fbies.201900162
PMID 32128850
PQID 2390479902
PQPubID 37030
PageCount 16
ParticipantIDs proquest_miscellaneous_2524217375
proquest_miscellaneous_2371143985
proquest_journals_2390479902
pubmed_primary_32128850
crossref_citationtrail_10_1002_bies_201900162
crossref_primary_10_1002_bies_201900162
wiley_primary_10_1002_bies_201900162_BIES201900162
PublicationCentury 2000
PublicationDate May 2020
PublicationDateYYYYMMDD 2020-05-01
PublicationDate_xml – month: 05
  year: 2020
  text: May 2020
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Cambridge
PublicationTitle BioEssays
PublicationTitleAlternate Bioessays
PublicationYear 2020
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 1991; 10
2013; 126
2004; 7
2004; 24
2002; 99
2019; 17
2016; 30
2012; 18
2017; 152
2016; 38
2003; 278
2016; 36
2016; 35
1998; 273
1994; 264
1998; 17
2007; 179
2000; 19
2008; 29
2017; 77
2019; 26
2008; 28
2013; 52
2019; 27
2019; 158
2008; 22
2013; 110
2012; 26
2012; 23
1996; 135
2012; 22
2010; 6
2011; 138
2007; 18
2019; 35
1996; 93
2010; 285
2016; 18
2012; 36
2016; 16
2011; 5
2017; 137
2016; 13
2016; 12
2001; 20
2016; 6
2016; 7
2016; 2
2018; 119
2018; 475
2018; 115
2019; 49
2016; 215
2019; 294
2018; 99
2016; 26
2011; 144
2016; 9
2006; 103
2017; 42
2013; 26
2013; 25
2013; 201
2008; 8
2017; 350
2007; 31
2017; 114
2017; 117
2017; 31
2013; 15
2017; 37
2017; 36
2013; 13
1999; 18
2017; 38
2007; 130
2003; 3
2008; 68
2001; 15
2019; 515
2017; 242
2018; 78
2014; 9
2010; 70
2007; 21
2006; 126
2014; 7
2017; 127
2006; 125
2014; 289
2018; 79
2015; 162
2015; 163
2015; 6
2007; 129
2015; 5
2017; 25
2006; 16
2017; 21
2007; 120
2010; 363
2000; 275
2017; 109
2014; 507
2011; 108
2017; 15
2013; 32
2017; 10
1999; 274
2019
2018
2017; 19
2018; 51
2015
2018; 50
2014
2013
2016; 130
2018; 59
2010; 11
1991; 113
2013; 2
2010; 107
2010; 19
1997; 272
2015; 75
2002; 277
2014; 26
1999; 283
2016; 143
2014; 28
2012; 367
2013; 8
2014; 133
2014; 134
2018; 7
2018; 6
2009; 11
2018; 9
2018; 8
2010; 20
2010; 24
2018; 293
2011; 71
2009; 122
2007; 2
2006; 281
2018; 32
2009; 16
2018; 37
2016; 151
2014; 124
2018; 188
2018; 29
2015; 526
1998; 63
2018; 22
2014; 158
1995; 6
2012; 109
2018; 25
2018; 24
2015; 67
2018; 19
2018; 17
2007; 316
2005; 122
2000; 103
2015; 62
2015; 519
2016; 291
2018; 10
2018; 16
2014; 33
2018; 15
2014; 32
2015; 35
2015; 34
2017; 8
2018; 128
2016; 76
2011; 11
2019; 129
2015; 348
2003; 113
2019; 363
2005; 25
2015; 46
2015; 210
2018; 379
1999; 98
2009; 284
2015; 13
2009; 23
2015; 17
2018; 145
2015; 11
2008; 14
2011; 30
2017; 170
1988; 55
2017; 171
2017; 292
2011; 32
2013; 140
2014; 111
1994; 9
2012; 150
2012; 151
2015; 23
2015; 26
2009; 30
1995; 81
2015; 29
2007; 2007
2015; 21
2013; 133
2013; 493
2016; 61
e_1_2_4_217_1
e_1_2_4_172_1
e_1_2_4_232_1
e_1_2_4_255_1
e_1_2_4_278_1
e_1_2_4_80_1
e_1_2_4_281_1
e_1_2_4_42_1
e_1_2_4_65_1
e_1_2_4_27_1
e_1_2_4_88_1
e_1_2_4_100_1
e_1_2_4_123_1
e_1_2_4_146_1
e_1_2_4_169_1
(e_1_2_4_119_1) 2019
e_1_2_4_161_1
e_1_2_4_184_1
e_1_2_4_228_1
e_1_2_4_1_1
e_1_2_4_205_1
e_1_2_4_220_1
e_1_2_4_243_1
e_1_2_4_266_1
e_1_2_4_9_1
e_1_2_4_92_1
e_1_2_4_31_1
e_1_2_4_77_1
e_1_2_4_54_1
e_1_2_4_16_1
e_1_2_4_112_1
e_1_2_4_135_1
e_1_2_4_158_1
e_1_2_4_39_1
e_1_2_4_194_1
e_1_2_4_196_1
e_1_2_4_218_1
e_1_2_4_171_1
e_1_2_4_210_1
e_1_2_4_256_1
e_1_2_4_279_1
e_1_2_4_81_1
e_1_2_4_233_1
e_1_2_4_20_1
e_1_2_4_66_1
e_1_2_4_43_1
e_1_2_4_282_1
e_1_2_4_107_1
e_1_2_4_89_1
e_1_2_4_28_1
e_1_2_4_145_1
e_1_2_4_168_1
e_1_2_4_122_1
Irvine K. D. (e_1_2_4_12_1) 2015
e_1_2_4_206_1
e_1_2_4_229_1
e_1_2_4_183_1
e_1_2_4_160_1
e_1_2_4_2_1
e_1_2_4_70_1
e_1_2_4_93_1
e_1_2_4_221_1
e_1_2_4_244_1
e_1_2_4_32_1
e_1_2_4_55_1
e_1_2_4_78_1
e_1_2_4_270_1
e_1_2_4_17_1
e_1_2_4_134_1
e_1_2_4_157_1
e_1_2_4_111_1
e_1_2_4_195_1
e_1_2_4_215_1
e_1_2_4_238_1
e_1_2_4_170_1
e_1_2_4_82_1
e_1_2_4_230_1
e_1_2_4_253_1
e_1_2_4_276_1
e_1_2_4_21_1
e_1_2_4_44_1
e_1_2_4_67_1
e_1_2_4_106_1
e_1_2_4_129_1
e_1_2_4_29_1
(e_1_2_4_60_1) 2018; 16
e_1_2_4_167_1
e_1_2_4_121_1
e_1_2_4_144_1
e_1_2_4_182_1
e_1_2_4_249_1
e_1_2_4_226_1
(e_1_2_4_132_1) 2019
e_1_2_4_7_1
e_1_2_4_94_1
e_1_2_4_241_1
e_1_2_4_203_1
e_1_2_4_264_1
e_1_2_4_71_1
e_1_2_4_10_1
e_1_2_4_56_1
e_1_2_4_33_1
e_1_2_4_118_1
e_1_2_4_79_1
e_1_2_4_18_1
e_1_2_4_156_1
e_1_2_4_179_1
e_1_2_4_192_1
e_1_2_4_110_1
e_1_2_4_133_1
e_1_2_4_239_1
e_1_2_4_216_1
e_1_2_4_83_1
e_1_2_4_231_1
e_1_2_4_277_1
e_1_2_4_45_1
e_1_2_4_280_1
e_1_2_4_22_1
e_1_2_4_105_1
e_1_2_4_128_1
e_1_2_4_68_1
e_1_2_4_189_1
e_1_2_4_120_1
e_1_2_4_166_1
e_1_2_4_143_1
e_1_2_4_204_1
e_1_2_4_227_1
e_1_2_4_181_1
Tsujiura M. (e_1_2_4_140_1) 2014
e_1_2_4_242_1
e_1_2_4_95_1
e_1_2_4_8_1
e_1_2_4_72_1
e_1_2_4_265_1
e_1_2_4_11_1
e_1_2_4_34_1
e_1_2_4_117_1
e_1_2_4_57_1
e_1_2_4_19_1
e_1_2_4_178_1
e_1_2_4_155_1
e_1_2_4_193_1
e_1_2_4_259_1
e_1_2_4_84_1
e_1_2_4_213_1
e_1_2_4_236_1
e_1_2_4_251_1
e_1_2_4_274_1
e_1_2_4_61_1
e_1_2_4_23_1
e_1_2_4_127_1
e_1_2_4_46_1
e_1_2_4_69_1
e_1_2_4_104_1
e_1_2_4_142_1
e_1_2_4_165_1
e_1_2_4_188_1
(e_1_2_4_47_1) 2018
e_1_2_4_180_1
e_1_2_4_5_1
e_1_2_4_209_1
e_1_2_4_96_1
e_1_2_4_247_1
e_1_2_4_262_1
e_1_2_4_285_1
e_1_2_4_73_1
e_1_2_4_224_1
e_1_2_4_50_1
e_1_2_4_201_1
(e_1_2_4_115_1) 2019
e_1_2_4_250_1
e_1_2_4_116_1
e_1_2_4_139_1
e_1_2_4_35_1
e_1_2_4_58_1
e_1_2_4_190_1
Yu O. M. (e_1_2_4_267_1) 2016; 36
e_1_2_4_154_1
e_1_2_4_177_1
e_1_2_4_237_1
e_1_2_4_85_1
(e_1_2_4_131_1) 2018; 17
e_1_2_4_62_1
e_1_2_4_214_1
e_1_2_4_252_1
e_1_2_4_275_1
e_1_2_4_24_1
Maitra A. (e_1_2_4_163_1) 2013
e_1_2_4_126_1
e_1_2_4_141_1
e_1_2_4_187_1
e_1_2_4_164_1
Huang C. Y. (e_1_2_4_149_1) 2018; 22
e_1_2_4_248_1
e_1_2_4_6_1
e_1_2_4_240_1
e_1_2_4_51_1
e_1_2_4_74_1
e_1_2_4_202_1
e_1_2_4_225_1
e_1_2_4_263_1
e_1_2_4_286_1
e_1_2_4_13_1
e_1_2_4_36_1
e_1_2_4_59_1
e_1_2_4_97_1
e_1_2_4_138_1
(e_1_2_4_41_1) 2018
e_1_2_4_191_1
e_1_2_4_130_1
e_1_2_4_176_1
e_1_2_4_153_1
e_1_2_4_151_1
e_1_2_4_197_1
e_1_2_4_219_1
e_1_2_4_257_1
Elbediwy A. (e_1_2_4_199_1) 2018
e_1_2_4_40_1
e_1_2_4_63_1
e_1_2_4_211_1
e_1_2_4_234_1
e_1_2_4_260_1
e_1_2_4_283_1
e_1_2_4_25_1
e_1_2_4_48_1
e_1_2_4_86_1
e_1_2_4_125_1
e_1_2_4_148_1
(e_1_2_4_212_1) 2018
e_1_2_4_102_1
e_1_2_4_186_1
(e_1_2_4_103_1) 2019
e_1_2_4_207_1
e_1_2_4_268_1
e_1_2_4_52_1
e_1_2_4_90_1
e_1_2_4_222_1
e_1_2_4_245_1
Huang C. (e_1_2_4_108_1) 2019
e_1_2_4_75_1
e_1_2_4_271_1
e_1_2_4_14_1
e_1_2_4_98_1
e_1_2_4_37_1
e_1_2_4_114_1
e_1_2_4_137_1
e_1_2_4_152_1
e_1_2_4_175_1
e_1_2_4_150_1
e_1_2_4_173_1
e_1_2_4_198_1
e_1_2_4_258_1
e_1_2_4_235_1
e_1_2_4_273_1
e_1_2_4_109_1
e_1_2_4_64_1
e_1_2_4_261_1
e_1_2_4_49_1
e_1_2_4_87_1
e_1_2_4_26_1
e_1_2_4_124_1
e_1_2_4_147_1
Sudol M. (e_1_2_4_3_1) 1994; 9
e_1_2_4_101_1
e_1_2_4_185_1
e_1_2_4_162_1
e_1_2_4_208_1
e_1_2_4_4_1
Park M. Y. (e_1_2_4_254_1) 2007; 31
e_1_2_4_269_1
e_1_2_4_246_1
e_1_2_4_284_1
e_1_2_4_30_1
e_1_2_4_91_1
e_1_2_4_200_1
e_1_2_4_223_1
e_1_2_4_53_1
e_1_2_4_76_1
e_1_2_4_272_1
e_1_2_4_15_1
e_1_2_4_38_1
e_1_2_4_99_1
e_1_2_4_113_1
e_1_2_4_159_1
e_1_2_4_136_1
e_1_2_4_174_1
References_xml – volume: 137
  start-page: 716
  year: 2017
  publication-title: J. Invest. Dermatol.
– volume: 9
  start-page: 5892
  year: 2018
  publication-title: Oncotarget
– volume: 107
  start-page: 8248
  year: 2010
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 179
  start-page: 1027
  year: 2007
  publication-title: J. Cell Biol.
– volume: 38
  start-page: 427
  year: 2017
  publication-title: Oncol. Rep.
– volume: 293
  year: 2018
  publication-title: J. Biol. Chem.
– volume: 32
  start-page: 1265
  year: 2014
  publication-title: Oncol. Rep.
– volume: 363
  start-page: 644
  year: 2019
  publication-title: Science
– volume: 25
  start-page: 5859
  year: 2005
  publication-title: Mol. Cell. Biol.
– volume: 37
  start-page: 216
  year: 2018
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 15
  start-page: 645
  year: 2018
  publication-title: Int. J. Med. Sci.
– volume: 162
  start-page: 780
  year: 2015
  publication-title: Cell
– volume: 23
  start-page: 803
  year: 2012
  publication-title: Semin. Cell. Dev. Biol.
– volume: 79
  start-page: 55
  year: 2018
  publication-title: Oral. Oncol.
– volume: 10
  start-page: 115
  year: 2018
  publication-title: Cancers
– volume: 37
  start-page: 280
  year: 2018
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 52
  start-page: 775
  year: 2013
  publication-title: Genes, Chromosomes Cancer
– volume: 36
  start-page: 503
  year: 2012
  publication-title: Immunity
– volume: 26
  start-page: 2138
  year: 2012
  publication-title: Genes Dev.
– volume: 17
  start-page: 6289
  year: 1998
  publication-title: EMBO J.
– volume: 19
  start-page: 507
  year: 2010
  publication-title: Dev. Cell
– volume: 10
  start-page: 15
  year: 2017
  publication-title: Dis. Models Mech.
– volume: 26
  start-page: 157
  year: 2013
  publication-title: Int. J. Immunopathol. Pharmacol.
– volume: 210
  start-page: 503
  year: 2015
  publication-title: J. Cell Biol.
– volume: 152
  start-page: 616
  year: 2017
  publication-title: Gastroenterology
– volume: 122
  start-page: 1059
  year: 2009
  publication-title: J. Cell Sci.
– volume: 117
  start-page: 884
  year: 2017
  publication-title: Br. J. Cancer
– volume: 158
  start-page: 143
  year: 2019
  publication-title: Cell
– volume: 31
  start-page: 2361
  year: 2017
  publication-title: Genes Dev.
– volume: 59
  start-page: 209
  year: 2018
  publication-title: Endocrine
– year: 2019
  publication-title: Cells
– volume: 24
  start-page: 3312
  year: 2018
  publication-title: Cell Rep.
– volume: 272
  start-page: 4637
  year: 1997
  publication-title: J. Biol. Chem.
– volume: 35
  start-page: 127
  year: 2016
  publication-title: Oncol. Rep.
– volume: 274
  year: 1999
  publication-title: J. Biol. Chem.
– volume: 7
  year: 2018
  publication-title: Elife
– volume: 11
  start-page: 353
  year: 2010
  publication-title: Nat. Rev. Mol. Cell Biol.
– volume: 2007
  start-page: pe35
  year: 2007
  publication-title: Sci. STKE
– volume: 19
  start-page: 27
  year: 2010
  publication-title: Dev. Cell
– year: 2019
  publication-title: Int. J. Cancer
– volume: 22
  start-page: 1962
  year: 2008
  publication-title: Genes Dev.
– volume: 25
  start-page: 702
  year: 2018
  publication-title: Cell Rep.
– volume: 274
  start-page: 8335
  year: 1999
  publication-title: J. Biol. Chem.
– volume: 18
  start-page: 2551
  year: 1999
  publication-title: EMBO J.
– volume: 26
  start-page: 2101
  year: 2016
  publication-title: Curr. Biol.
– start-page: 4
  year: 2013
  publication-title: Nat. Commun.
– volume: 15
  start-page: 637
  year: 2013
  publication-title: Nat. Cell Biol.
– volume: 36
  start-page: 2811
  year: 2016
  publication-title: Mol. Cell. Biol.
– volume: 201
  start-page: 875
  year: 2013
  publication-title: J. Cell. Biol.
– volume: 75
  start-page: 4450
  year: 2015
  publication-title: Cancer Res.
– volume: 21
  start-page: 1896
  year: 2017
  publication-title: Cell Rep.
– volume: 38
  start-page: 644
  year: 2016
  publication-title: BioEssays
– volume: 126
  start-page: 767
  year: 2006
  publication-title: Cell
– volume: 28
  start-page: 432
  year: 2014
  publication-title: Genes Dev.
– volume: 114
  year: 2017
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 25
  start-page: 581
  year: 2017
  publication-title: Appl. Immunohistochem. Mol. Morphol.
– volume: 78
  start-page: 1083
  year: 2018
  publication-title: Cancer Res.
– volume: 9
  start-page: 2145
  year: 1994
  publication-title: Oncogene
– volume: 29
  start-page: 2372
  year: 2018
  publication-title: J. Am. Soc. Nephrol.
– volume: 37
  start-page: 69
  year: 2018
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 19
  year: 2017
  publication-title: Neuro‐Oncology
– year: 2018
  publication-title: J. Cell. Sci.
– volume: 507
  start-page: 190
  year: 2014
  publication-title: Nature
– volume: 125
  start-page: 1253
  year: 2006
  publication-title: Cell
– volume: 277
  year: 2002
  publication-title: J. Biol. Chem.
– volume: 115
  start-page: 447
  year: 2018
  publication-title: Free Rad. Biol. Med.
– volume: 107
  start-page: 1437
  year: 2010
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 138
  start-page: 3907
  year: 2011
  publication-title: Development
– volume: 281
  start-page: 2676
  year: 2006
  publication-title: J. Biol. Chem.
– volume: 127
  start-page: 3441
  year: 2017
  publication-title: J. Clin. Invest.
– volume: 133
  start-page: 23
  year: 2014
  publication-title: Mech. Dev.
– volume: 113
  start-page: 329
  year: 2003
  publication-title: Cell
– volume: 17
  start-page: 6622
  year: 1998
  publication-title: EMBO J.
– volume: 33
  start-page: 468
  year: 2014
  publication-title: EMBO J.
– volume: 16
  start-page: 3949
  year: 2018
  publication-title: Oncol. Lett.
– volume: 8
  year: 2017
  publication-title: Oncotarget
– volume: 30
  start-page: 249
  year: 2009
  publication-title: Carcinogenesis
– volume: 6
  start-page: 255
  year: 2018
  publication-title: Cancer Immunol. Res.
– volume: 10
  start-page: 933
  year: 1991
  publication-title: EMBO J.
– volume: 71
  start-page: 2706
  year: 2011
  publication-title: Cancer Res.
– volume: 16
  start-page: 425
  year: 2009
  publication-title: Cancer Cell
– volume: 8
  start-page: 427
  year: 2008
  publication-title: Curr. Opin. Pharmacol.
– volume: 171
  start-page: 1397
  year: 2017
  publication-title: Cell
– volume: 109
  start-page: 4910
  year: 2012
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 7
  start-page: 85
  year: 2004
  publication-title: Dev. Cell
– volume: 28
  start-page: 732
  year: 2008
  publication-title: Mol. Cell. Biol.
– volume: 134
  start-page: 123
  year: 2014
  publication-title: J. Invest. Dermatol.
– volume: 158
  start-page: 171
  year: 2014
  publication-title: Cell
– volume: 7
  start-page: 2132
  year: 2016
  publication-title: J. Cancer
– volume: 17
  start-page: 95
  year: 2015
  publication-title: Nat. Cell Biol.
– volume: 31
  start-page: 1309
  year: 2007
  publication-title: Int. J. Oncol.
– volume: 8
  year: 2013
  publication-title: PLoS One
– volume: 30
  start-page: 2810
  year: 2011
  publication-title: Oncogene
– volume: 6
  year: 2015
  publication-title: Oncotarget
– volume: 18
  start-page: 1511
  year: 2012
  publication-title: Nat. Med.
– volume: 42
  start-page: 667
  year: 2017
  publication-title: Dev. Cell
– volume: 26
  start-page: 273
  year: 2014
  publication-title: Cancer Cell
– volume: 14
  start-page: 377
  year: 2008
  publication-title: Dev. Cell
– volume: 103
  start-page: 311
  year: 2000
  publication-title: Cell
– volume: 28
  start-page: 1048
  year: 2014
  publication-title: Genes Dev.
– volume: 21
  start-page: 4482
  year: 2015
  publication-title: Clin. Cancer Res.
– volume: 145
  year: 2018
  publication-title: Development
– volume: 15
  start-page: 929
  year: 2017
  publication-title: Mol. Cancer Res.
– volume: 7
  year: 2016
  publication-title: Oncotarget
– volume: 151
  start-page: 1457
  year: 2012
  publication-title: Cell
– volume: 99
  year: 2002
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 22
  start-page: 3320
  year: 2008
  publication-title: Genes Dev.
– volume: 133
  start-page: 1497
  year: 2013
  publication-title: J. Invest. Dermatol.
– volume: 24
  start-page: 2383
  year: 2010
  publication-title: Genes Dev.
– start-page: 131
  year: 2018
  publication-title: J. Cell Sci.
– volume: 8
  start-page: 3256
  year: 2018
  publication-title: Theranostics
– volume: 273
  year: 1998
  publication-title: J. Biol. Chem.
– volume: 107
  start-page: 1431
  year: 2010
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 37
  start-page: 5492
  year: 2018
  publication-title: Oncogene
– volume: 113
  start-page: 867
  year: 1991
  publication-title: J. Cell Biol.
– volume: 284
  year: 2009
  publication-title: J. Biol. Chem.
– volume: 292
  year: 2017
  publication-title: J. Biol. Chem.
– volume: 6
  start-page: 1349
  year: 1995
  publication-title: Mol. Biol. Cell
– volume: 67
  start-page: 699
  year: 2015
  publication-title: Histopathology
– volume: 3
  start-page: 11
  year: 2003
  publication-title: Nat. Rev. Cancer
– volume: 21
  start-page: 2747
  year: 2007
  publication-title: Genes Dev.
– volume: 109
  year: 2012
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 36
  start-page: 520
  year: 2017
  publication-title: EMBO J.
– volume: 35
  start-page: 457
  year: 2019
  publication-title: Cancer Cell
– volume: 28
  start-page: 2426
  year: 2008
  publication-title: Mol. Cell. Biol.
– volume: 493
  start-page: 106
  year: 2013
  publication-title: Nature
– volume: 278
  year: 2003
  publication-title: J. Biol. Chem.
– volume: 316
  start-page: 1749
  year: 2007
  publication-title: Science
– volume: 151
  start-page: 526
  year: 2016
  publication-title: Gastroenterology
– volume: 18
  start-page: 1083
  year: 2007
  publication-title: Mol. Biol. Cell
– volume: 99
  start-page: 37
  year: 2018
  publication-title: Eur. J. Cancer
– volume: 20
  start-page: 1594
  year: 2001
  publication-title: Oncogene
– volume: 19
  start-page: 337
  year: 2018
  publication-title: EMBO Rep.
– volume: 114
  start-page: 1678
  year: 2017
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 29
  start-page: 15
  year: 2018
  publication-title: Stem Cell Res.
– volume: 36
  start-page: 1232
  year: 2017
  publication-title: Oncogene
– volume: 22
  start-page: 651
  year: 2012
  publication-title: Curr. Biol.
– volume: 27
  start-page: 1103
  year: 2019
  publication-title: Cell Rep.
– volume: 51
  start-page: 97
  year: 2018
  publication-title: Curr. Opin. Cell Biol.
– volume: 519
  start-page: 57
  year: 2015
  publication-title: Nature
– volume: 34
  start-page: 681
  year: 2015
  publication-title: Oncogene
– volume: 526
  start-page: 715
  year: 2015
  publication-title: Nature
– start-page: 8
  year: 2019
  publication-title: Cells
– volume: 17
  start-page: 1435
  year: 2019
  publication-title: Mol. Cancer Res.
– volume: 81
  start-page: 1159
  year: 1995
  publication-title: Cell
– volume: 29
  start-page: 1493
  year: 2015
  publication-title: Genes Dev.
– volume: 16
  start-page: 1046
  year: 2018
  publication-title: Mol. Cancer Res.
– volume: 25
  start-page: 1304
  year: 2018
  publication-title: Cell Rep.
– volume: 36
  start-page: 39
  year: 2016
  publication-title: Mol Cell Biol
– volume: 34
  start-page: 3536
  year: 2015
  publication-title: Oncogene
– volume: 16
  start-page: 1556
  year: 2018
  publication-title: Mol. Cancer Res.
– volume: 31
  start-page: 247
  year: 2017
  publication-title: Genes Dev.
– volume: 8
  year: 2017
  publication-title: Nat. Commun.
– volume: 475
  start-page: 2043
  year: 2018
  publication-title: Biochem. J.
– volume: 348
  start-page: 1024
  year: 2015
  publication-title: Science
– volume: 294
  start-page: 2302
  year: 2019
  publication-title: J. Biol. Chem.
– volume: 9
  start-page: 464
  year: 2018
  publication-title: Cell Death Dis.
– volume: 49
  start-page: 425
  year: 2019
  publication-title: Dev. Cell
– volume: 22
  start-page: 35
  year: 2018
  publication-title: Cell Stem Cell
– volume: 10
  year: 2018
  publication-title: EMBO Mol. Med.
– volume: 78
  start-page: 1457
  year: 2018
  publication-title: Cancer Res.
– volume: 19
  start-page: 6778
  year: 2000
  publication-title: EMBO J.
– volume: 215
  start-page: 445
  year: 2016
  publication-title: J. Cell Biol.
– volume: 13
  start-page: 349
  year: 2013
  publication-title: BMC Cancer
– volume: 367
  start-page: 187
  year: 2012
  publication-title: Dev. Biol.
– volume: 30
  start-page: 798
  year: 2016
  publication-title: Genes Dev.
– volume: 14
  start-page: 388
  year: 2008
  publication-title: Dev. Cell
– volume: 2
  year: 2013
  publication-title: Oncogenesis
– volume: 135
  start-page: 1633
  year: 1996
  publication-title: J. Cell Biol.
– volume: 9
  start-page: 4015
  year: 2016
  publication-title: OncoTargets Ther.
– volume: 144
  start-page: 782
  year: 2011
  publication-title: Cell
– volume: 110
  year: 2013
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 50
  year: 2018
  publication-title: Exp. Mol. Med.
– volume: 32
  start-page: 318
  year: 2013
  publication-title: Oncogene
– start-page: 7
  year: 2018
  publication-title: Elife
– volume: 11
  start-page: 57
  year: 2011
  publication-title: BMC Dev. Biol.
– volume: 77
  start-page: 4868
  year: 2017
  publication-title: Cancer Res.
– volume: 143
  start-page: 1674
  year: 2016
  publication-title: Development
– volume: 32
  start-page: 1594
  year: 2014
  publication-title: Oncol. Rep.
– volume: 103
  year: 2006
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 283
  start-page: 655
  year: 1999
  publication-title: Science
– volume: 124
  start-page: 2013
  year: 2014
  publication-title: Blood
– volume: 29
  start-page: 2139
  year: 2008
  publication-title: Carcinogenesis
– volume: 21
  start-page: 2663
  year: 2017
  publication-title: J. Cell. Mol. Med.
– volume: 129
  start-page: 465
  year: 2007
  publication-title: Cell
– volume: 2
  start-page: 2
  year: 2007
  publication-title: J. Mol. Signal.
– volume: 32
  start-page: 389
  year: 2011
  publication-title: Carcinogenesis
– volume: 5
  year: 2015
  publication-title: Sci. Rep.
– volume: 150
  start-page: 780
  year: 2012
  publication-title: Cell
– volume: 18
  start-page: 172
  year: 2016
  publication-title: Clin. Transl. Oncol.
– volume: 126
  start-page: 393
  year: 2013
  publication-title: J. Cell Sci.
– volume: 11
  year: 2015
  publication-title: PLoS Genet.
– volume: 140
  start-page: 4683
  year: 2013
  publication-title: Development
– volume: 274
  start-page: 1185
  year: 1999
  publication-title: J. Biol. Chem.
– volume: 18
  start-page: 3214
  year: 2007
  publication-title: Mol. Biol. Cell
– volume: 26
  start-page: 2636
  year: 2019
  publication-title: Cell Rep.
– volume: 37
  start-page: 2620
  year: 2017
  publication-title: Oncol. Rep.
– volume: 35
  start-page: 868
  year: 2019
  publication-title: Cancer Cell
– start-page: 132
  year: 2019
  publication-title: J. Cell Sci.
– volume: 12
  start-page: 1821
  year: 2016
  publication-title: Oncol. Lett.
– volume: 26
  start-page: 1249
  year: 2015
  publication-title: Mol. Biol. Cell
– volume: 111
  start-page: 255
  year: 2014
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– year: 2014
  publication-title: PLoS One
– volume: 9
  start-page: 269
  year: 2018
  publication-title: Cell Death Dis.
– volume: 70
  start-page: 8517
  year: 2010
  publication-title: Cancer Res.
– volume: 275
  year: 2000
  publication-title: J. Biol. Chem.
– volume: 9
  year: 2014
  publication-title: PLoS One
– volume: 163
  start-page: 811
  year: 2015
  publication-title: Cell
– volume: 62
  start-page: 1497
  year: 2015
  publication-title: Hepatology
– volume: 49
  start-page: 332
  year: 2019
  publication-title: Dev. Cell
– volume: 6
  start-page: 80
  year: 2016
  publication-title: Cancer Discovery
– volume: 379
  start-page: 2052
  year: 2018
  publication-title: N. Engl. J. Med.
– volume: 11
  start-page: 257
  year: 2009
  publication-title: Nat. Cell Biol.
– volume: 22
  start-page: 2351
  year: 2018
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 128
  start-page: 1010
  year: 2018
  publication-title: J. Clin. Invest.
– volume: 6
  start-page: 8126
  year: 2015
  publication-title: Nat. Commun.
– volume: 76
  start-page: 3813
  year: 2016
  publication-title: Cancer Res.
– volume: 129
  start-page: 2107
  year: 2019
  publication-title: J. Clin. Invest.
– volume: 291
  year: 2016
  publication-title: J. Biol. Chem.
– volume: 23
  start-page: 2076
  year: 2015
  publication-title: Structure
– volume: 46
  start-page: 2364
  year: 2015
  publication-title: Int. J. Oncol.
– volume: 68
  start-page: 2592
  year: 2008
  publication-title: Cancer Res.
– volume: 23
  start-page: 397
  year: 2009
  publication-title: Genes Dev.
– volume: 63
  start-page: 643
  year: 1998
  publication-title: Cold Spring Harbor Symp. Quant. Biol.
– volume: 114
  start-page: 1643
  year: 2017
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 138
  start-page: 9
  year: 2011
  publication-title: Development
– volume: 350
  start-page: 218
  year: 2017
  publication-title: Exp. Cell Res.
– volume: 98
  start-page: 159
  year: 1999
  publication-title: Cell
– volume: 35
  start-page: 1350
  year: 2015
  publication-title: Mol. Cell. Biol.
– volume: 16
  start-page: 588
  year: 2006
  publication-title: Trends Cell Biol.
– volume: 108
  year: 2011
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 122
  start-page: 421
  year: 2005
  publication-title: Cell
– volume: 15
  start-page: 1229
  year: 2001
  publication-title: Genes. Dev.
– volume: 285
  year: 2010
  publication-title: J. Biol. Chem.
– volume: 130
  start-page: 349
  year: 2016
  publication-title: Clin. Sci.
– volume: 120
  start-page: 1801
  year: 2007
  publication-title: J. Cell Sci.
– volume: 17
  start-page: 1218
  year: 2015
  publication-title: Nat. Cell Biol.
– volume: 109
  year: 2017
  publication-title: J. Natl. Cancer Inst.
– volume: 264
  start-page: 95
  year: 1994
  publication-title: Science
– volume: 61
  start-page: S177
  year: 2016
  publication-title: Eur. J. Cancer
– volume: 242
  start-page: 476
  year: 2017
  publication-title: J. Pathol.
– volume: 515
  start-page: 275
  year: 2019
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 110
  start-page: 2569
  year: 2013
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– start-page: 8
  year: 2019
  publication-title: Elife
– volume: 20
  start-page: 657
  year: 2010
  publication-title: Curr. Biol.
– volume: 363
  start-page: 2191
  year: 2010
  publication-title: N. Engl. J. Med.
– volume: 16
  start-page: 1810
  year: 2016
  publication-title: Cell Rep.
– volume: 51
  start-page: 22
  year: 2018
  publication-title: Curr. Opin. Cell Biol.
– volume: 35
  start-page: 1541
  year: 2016
  publication-title: Oncogene
– volume: 2
  year: 2016
  publication-title: npj Breast Cancer
– volume: 6
  year: 2010
  publication-title: PLoS Genet.
– volume: 55
  start-page: 989
  year: 1988
  publication-title: Cell
– volume: 130
  start-page: 1120
  year: 2007
  publication-title: Cell
– start-page: 19
  year: 2018
  publication-title: EMBO Rep.
– volume: 170
  start-page: 605
  year: 2017
  publication-title: Cell
– volume: 13
  start-page: 237
  year: 2016
  publication-title: Mol. Med. Rep.
– volume: 5
  start-page: 360
  year: 2011
  publication-title: Cell Adhes. Migr.
– publication-title: J Cell Sci.
– volume: 289
  year: 2014
  publication-title: J. Biol. Chem.
– volume: 7
  start-page: ra42
  year: 2014
  publication-title: Sci. Signaling
– volume: 20
  start-page: 1601
  year: 2001
  publication-title: Oncogene
– year: 2015
  publication-title: Cold Spring Harbor Perspect. Biol.
– volume: 277
  start-page: 9405
  year: 2002
  publication-title: J. Biol. Chem.
– volume: 158
  start-page: 185
  year: 2014
  publication-title: Cell
– volume: 16
  start-page: 1895
  year: 2006
  publication-title: Curr. Biol.
– volume: 32
  start-page: 2037
  year: 2018
  publication-title: Leukemia
– volume: 17
  start-page: 3783
  year: 2018
  publication-title: Mol. Med. Rep.
– volume: 24
  start-page: 8586
  year: 2004
  publication-title: Mol. Cell. Biol.
– volume: 119
  start-page: 2258
  year: 2018
  publication-title: J. Cell. Biochem.
– volume: 108
  start-page: 2270
  year: 2011
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 188
  start-page: 995
  year: 2018
  publication-title: Am. J. Pathol.
– volume: 13
  start-page: 957
  year: 2015
  publication-title: Mol. Cancer Res.
– volume: 25
  start-page: 388
  year: 2013
  publication-title: Dev. Cell
– volume: 34
  start-page: 2764
  year: 2015
  publication-title: Oncogene
– volume: 26
  start-page: 1300
  year: 2012
  publication-title: Genes Dev.
– volume: 119
  start-page: 824
  year: 2018
  publication-title: J. Cell. Biochem.
– volume: 93
  start-page: 8425
  year: 1996
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– ident: e_1_2_4_68_1
  doi: 10.18632/oncotarget.22392
– ident: e_1_2_4_231_1
  doi: 10.1126/stke.3922007pe35
– ident: e_1_2_4_258_1
  doi: 10.1038/ncb1833
– volume: 36
  start-page: 39
  year: 2016
  ident: e_1_2_4_267_1
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.00772-15
– ident: e_1_2_4_107_1
  doi: 10.1158/0008-5472.CAN-17-2464
– year: 2015
  ident: e_1_2_4_12_1
  publication-title: Cold Spring Harbor Perspect. Biol.
– ident: e_1_2_4_18_1
  doi: 10.1016/j.cell.2006.07.013
– ident: e_1_2_4_52_1
  doi: 10.1038/nature12930
– ident: e_1_2_4_50_1
  doi: 10.1158/1541-7786.MCR-14-0580
– ident: e_1_2_4_118_1
  doi: 10.1093/neuonc/nox036.039
– ident: e_1_2_4_177_1
  doi: 10.1016/j.ccell.2019.05.003
– ident: e_1_2_4_164_1
  doi: 10.1016/j.celrep.2018.10.001
– ident: e_1_2_4_105_1
  doi: 10.18632/oncotarget.4043
– ident: e_1_2_4_19_1
  doi: 10.1016/j.cub.2006.08.057
– ident: e_1_2_4_26_1
  doi: 10.1016/j.cub.2012.02.050
– ident: e_1_2_4_127_1
  doi: 10.1158/0008-5472.CAN-10-1242
– ident: e_1_2_4_22_1
  doi: 10.1371/journal.pgen.1004994
– ident: e_1_2_4_136_1
  doi: 10.1016/j.freeradbiomed.2017.12.005
– ident: e_1_2_4_185_1
  doi: 10.1158/0008-5472.CAN-17-0391
– ident: e_1_2_4_247_1
  doi: 10.1016/0092-8674(88)90244-9
– ident: e_1_2_4_278_1
  doi: 10.1186/s13046-018-0892-2
– ident: e_1_2_4_186_1
  doi: 10.1074/jbc.RA118.004364
– ident: e_1_2_4_85_1
  doi: 10.1038/srep16759
– ident: e_1_2_4_162_1
  doi: 10.1016/j.cell.2006.05.030
– ident: e_1_2_4_187_1
  doi: 10.1101/gad.274951.115
– ident: e_1_2_4_80_1
  doi: 10.1073/pnas.1212021109
– ident: e_1_2_4_82_1
  doi: 10.1158/0008-5472.CAN-17-3139
– ident: e_1_2_4_30_1
  doi: 10.1038/nature14228
– volume: 17
  start-page: 3783
  year: 2018
  ident: e_1_2_4_131_1
  publication-title: Mol. Med. Rep.
– ident: e_1_2_4_155_1
  doi: 10.3892/or.2014.3305
– ident: e_1_2_4_90_1
  doi: 10.1158/1078-0432.CCR-15-0226
– ident: e_1_2_4_97_1
  doi: 10.1016/j.devcel.2010.06.015
– ident: e_1_2_4_260_1
  doi: 10.1074/jbc.M203130200
– ident: e_1_2_4_66_1
  doi: 10.1016/j.yexcr.2016.11.024
– ident: e_1_2_4_34_1
  doi: 10.1038/emm.2017.205
– ident: e_1_2_4_269_1
  doi: 10.1016/S0092-8674(00)00122-7
– ident: e_1_2_4_207_1
  doi: 10.1083/jcb.201609037
– ident: e_1_2_4_198_1
  doi: 10.1093/jnci/djx014
– ident: e_1_2_4_234_1
  doi: 10.1016/j.celrep.2018.08.061
– ident: e_1_2_4_124_1
  doi: 10.1371/journal.pone.0109575
– start-page: 8
  year: 2019
  ident: e_1_2_4_115_1
  publication-title: Elife
– ident: e_1_2_4_145_1
  doi: 10.1038/oncsis.2013.12
– ident: e_1_2_4_274_1
  doi: 10.1016/j.cell.2007.04.019
– ident: e_1_2_4_24_1
  doi: 10.1016/j.cub.2016.06.035
– ident: e_1_2_4_57_1
  doi: 10.18632/oncotarget.22865
– ident: e_1_2_4_157_1
  doi: 10.1002/gcc.22073
– ident: e_1_2_4_76_1
  doi: 10.1158/0008-5472.CAN-07-2696
– ident: e_1_2_4_243_1
  doi: 10.1016/j.ccell.2019.01.009
– ident: e_1_2_4_91_1
  doi: 10.3892/mmr.2015.4550
– ident: e_1_2_4_130_1
  doi: 10.1016/S0959-8049(16)61627-1
– ident: e_1_2_4_129_1
  doi: 10.1038/ncomms9126
– ident: e_1_2_4_196_1
  doi: 10.18632/oncotarget.5971
– ident: e_1_2_4_200_1
  doi: 10.1016/j.ceb.2017.12.003
– ident: e_1_2_4_224_1
  doi: 10.1016/j.cell.2015.07.013
– ident: e_1_2_4_179_1
  doi: 10.1016/j.devcel.2019.03.026
– ident: e_1_2_4_184_1
  doi: 10.1242/dev.070987
– volume: 16
  start-page: 3949
  year: 2018
  ident: e_1_2_4_60_1
  publication-title: Oncol. Lett.
– ident: e_1_2_4_122_1
  doi: 10.2147/OTT.S102733
– ident: e_1_2_4_148_1
  doi: 10.1007/s12020-017-1240-6
– year: 2014
  ident: e_1_2_4_140_1
  publication-title: PLoS One
– ident: e_1_2_4_201_1
  doi: 10.1091/mbc.6.10.1349
– ident: e_1_2_4_33_1
  doi: 10.1073/pnas.1313192110
– ident: e_1_2_4_208_1
  doi: 10.1242/jcs.039446
– ident: e_1_2_4_275_1
  doi: 10.1002/path.4922
– ident: e_1_2_4_42_1
  doi: 10.1016/j.cell.2014.06.004
– start-page: 131
  year: 2018
  ident: e_1_2_4_212_1
  publication-title: J. Cell Sci.
– ident: e_1_2_4_27_1
  doi: 10.1101/gad.1978810
– ident: e_1_2_4_70_1
  doi: 10.1038/onc.2012.53
– ident: e_1_2_4_188_1
  doi: 10.7150/thno.23964
– ident: e_1_2_4_173_1
  doi: 10.1158/1541-7786.MCR-17-0593
– ident: e_1_2_4_206_1
  doi: 10.1128/MCB.24.19.8586-8599.2004
– ident: e_1_2_4_72_1
  doi: 10.1128/MCB.01874-07
– ident: e_1_2_4_137_1
  doi: 10.7150/jca.16438
– ident: e_1_2_4_65_1
  doi: 10.1371/journal.pone.0065539
– ident: e_1_2_4_227_1
  doi: 10.1038/bjc.2017.259
– ident: e_1_2_4_37_1
  doi: 10.1073/pnas.1704030114
– ident: e_1_2_4_176_1
  doi: 10.1158/1541-7786.MCR-17-0023
– ident: e_1_2_4_135_1
  doi: 10.7150/ijms.23460
– ident: e_1_2_4_151_1
  doi: 10.1093/carcin/bgn200
– ident: e_1_2_4_168_1
  doi: 10.1056/NEJMra1704560
– ident: e_1_2_4_111_1
  doi: 10.1126/science.aav0173
– ident: e_1_2_4_204_1
  doi: 10.1073/pnas.93.16.8425
– ident: e_1_2_4_253_1
  doi: 10.1242/jcs.001586
– ident: e_1_2_4_219_1
  doi: 10.4161/cam.5.4.17290
– ident: e_1_2_4_20_1
  doi: 10.1016/j.devcel.2010.09.009
– ident: e_1_2_4_98_1
  doi: 10.1172/JCI95802
– ident: e_1_2_4_214_1
  doi: 10.15252/embr.201744777
– ident: e_1_2_4_43_1
  doi: 10.1016/j.cell.2011.02.031
– ident: e_1_2_4_146_1
  doi: 10.1097/PAI.0000000000000344
– ident: e_1_2_4_217_1
  doi: 10.1083/jcb.113.4.867
– ident: e_1_2_4_221_1
  doi: 10.1074/jbc.M110.119909
– ident: e_1_2_4_126_1
  doi: 10.1038/onc.2011.8
– ident: e_1_2_4_17_1
  doi: 10.1016/j.devcel.2008.01.006
– ident: e_1_2_4_51_1
  doi: 10.3892/ijo.2015.2948
– ident: e_1_2_4_248_1
  doi: 10.1016/j.devcel.2004.05.020
– ident: e_1_2_4_144_1
  doi: 10.1016/j.devcel.2019.04.014
– ident: e_1_2_4_256_1
  doi: 10.1083/jcb.200708174
– ident: e_1_2_4_71_1
  doi: 10.1158/0008-5472.CAN-10-0738
– ident: e_1_2_4_75_1
  doi: 10.1101/gad.1664408
– ident: e_1_2_4_21_1
  doi: 10.1371/journal.pgen.1001140
– start-page: 7
  year: 2018
  ident: e_1_2_4_47_1
  publication-title: Elife
– ident: e_1_2_4_191_1
  doi: 10.18632/oncotarget.23638
– ident: e_1_2_4_102_1
  doi: 10.1016/j.bbrc.2019.05.143
– ident: e_1_2_4_235_1
  doi: 10.1074/jbc.274.3.1185
– volume: 31
  start-page: 1309
  year: 2007
  ident: e_1_2_4_254_1
  publication-title: Int. J. Oncol.
– ident: e_1_2_4_94_1
  doi: 10.1073/pnas.0912203107
– ident: e_1_2_4_101_1
  doi: 10.1007/s12094-015-1353-4
– ident: e_1_2_4_81_1
  doi: 10.15252/embj.201695137
– ident: e_1_2_4_23_1
  doi: 10.1186/1471-213X-11-57
– ident: e_1_2_4_182_1
  doi: 10.1101/gad.1758709
– ident: e_1_2_4_263_1
  doi: 10.1016/S0092-8674(00)81011-9
– ident: e_1_2_4_277_1
  doi: 10.1002/jcb.26388
– ident: e_1_2_4_95_1
  doi: 10.1073/pnas.0911427107
– ident: e_1_2_4_8_1
  doi: 10.1083/jcb.201210073
– ident: e_1_2_4_240_1
  doi: 10.1074/jbc.272.7.4637
– ident: e_1_2_4_99_1
  doi: 10.18632/oncotarget.3546
– ident: e_1_2_4_6_1
  doi: 10.1101/gad.888601
– ident: e_1_2_4_284_1
  doi: 10.1042/BCJ20180225
– ident: e_1_2_4_189_1
  doi: 10.1016/j.ejca.2018.05.013
– ident: e_1_2_4_147_1
  doi: 10.18632/oncotarget.14319
– ident: e_1_2_4_120_1
  doi: 10.18632/oncotarget.15677
– ident: e_1_2_4_116_1
  doi: 10.1242/dmm.026500
– ident: e_1_2_4_141_1
  doi: 10.18632/oncotarget.15614
– ident: e_1_2_4_165_1
  doi: 10.1158/1541-7786.MCR-18-0407
– ident: e_1_2_4_262_1
  doi: 10.1016/S0092-8674(05)80020-0
– ident: e_1_2_4_53_1
  doi: 10.1073/pnas.1112499109
– ident: e_1_2_4_83_1
  doi: 10.1126/scisignal.2005049
– ident: e_1_2_4_28_1
  doi: 10.1038/nature15382
– ident: e_1_2_4_38_1
  doi: 10.7554/eLife.31037
– ident: e_1_2_4_203_1
  doi: 10.1083/jcb.135.6.1633
– ident: e_1_2_4_29_1
  doi: 10.1053/j.gastro.2016.11.005
– ident: e_1_2_4_283_1
  doi: 10.1101/gad.192856.112
– ident: e_1_2_4_161_1
  doi: 10.1016/j.celrep.2017.10.078
– ident: e_1_2_4_154_1
  doi: 10.1016/j.ccr.2014.05.029
– ident: e_1_2_4_270_1
  doi: 10.1016/j.scr.2018.03.005
– ident: e_1_2_4_197_1
  doi: 10.1016/j.cell.2012.11.026
– ident: e_1_2_4_272_1
  doi: 10.1016/j.immuni.2012.03.013
– ident: e_1_2_4_271_1
  doi: 10.1016/j.jid.2016.10.029
– ident: e_1_2_4_238_1
  doi: 10.1074/jbc.275.17.12619
– start-page: 8
  year: 2019
  ident: e_1_2_4_132_1
  publication-title: Cells
– ident: e_1_2_4_249_1
  doi: 10.1101/gad.237743.114
– ident: e_1_2_4_39_1
  doi: 10.1172/JCI93825
– ident: e_1_2_4_279_1
  doi: 10.1038/ncb3073
– start-page: 19
  year: 2018
  ident: e_1_2_4_41_1
  publication-title: EMBO Rep.
– ident: e_1_2_4_49_1
  doi: 10.1093/carcin/bgq254
– ident: e_1_2_4_77_1
  doi: 10.1038/onc.2014.5
– ident: e_1_2_4_245_1
  doi: 10.1016/j.tcb.2006.09.008
– ident: e_1_2_4_89_1
  doi: 10.18632/oncotarget.5772
– ident: e_1_2_4_265_1
  doi: 10.1128/MCB.01623-07
– ident: e_1_2_4_88_1
  doi: 10.1186/s13046-018-0740-4
– ident: e_1_2_4_128_1
  doi: 10.1038/onc.2014.206
– ident: e_1_2_4_159_1
  doi: 10.1038/s41375-018-0111-3
– ident: e_1_2_4_236_1
  doi: 10.1126/science.283.5402.655
– ident: e_1_2_4_169_1
  doi: 10.1016/j.cell.2017.07.029
– ident: e_1_2_4_113_1
  doi: 10.1101/gad.1726608
– ident: e_1_2_4_211_1
  doi: 10.1016/j.cell.2014.05.035
– ident: e_1_2_4_10_1
  doi: 10.1016/j.semcdb.2012.06.001
– ident: e_1_2_4_222_1
  doi: 10.1016/j.cell.2012.06.037
– ident: e_1_2_4_73_1
  doi: 10.1073/pnas.0605579103
– ident: e_1_2_4_160_1
  doi: 10.1038/npjbcancer.2016.17
– ident: e_1_2_4_286_1
  doi: 10.1074/jbc.RA118.005457
– ident: e_1_2_4_193_1
  doi: 10.1073/pnas.1620290114
– ident: e_1_2_4_230_1
  doi: 10.1182/blood-2014-01-453134
– ident: e_1_2_4_104_1
  doi: 10.1016/j.ajpath.2017.12.017
– ident: e_1_2_4_225_1
  doi: 10.1074/jbc.M116.739722
– ident: e_1_2_4_170_1
  doi: 10.1073/pnas.1216462110
– ident: e_1_2_4_59_1
  doi: 10.1038/s41419-018-0515-z
– ident: e_1_2_4_194_1
  doi: 10.1128/MCB.00311-16
– ident: e_1_2_4_180_1
  doi: 10.1016/j.coph.2008.06.012
– ident: e_1_2_4_55_1
  doi: 10.1016/j.celrep.2016.07.020
– ident: e_1_2_4_13_1
  doi: 10.1002/bies.201600037
– ident: e_1_2_4_226_1
  doi: 10.1056/NEJMoa1000584
– ident: e_1_2_4_252_1
  doi: 10.1002/j.1460-2075.1991.tb08027.x
– ident: e_1_2_4_192_1
  doi: 10.1073/pnas.1610223114
– ident: e_1_2_4_237_1
  doi: 10.1074/jbc.273.36.23110
– ident: e_1_2_4_172_1
  doi: 10.1038/s41419-018-0302-x
– ident: e_1_2_4_121_1
  doi: 10.3892/or.2017.5517
– ident: e_1_2_4_273_1
  doi: 10.1126/science.8140422
– ident: e_1_2_4_205_1
  doi: 10.1093/emboj/17.22.6622
– ident: e_1_2_4_181_1
  doi: 10.1242/jcs.100115
– ident: e_1_2_4_232_1
  doi: 10.1074/jbc.M507752200
– year: 2019
  ident: e_1_2_4_108_1
  publication-title: Int. J. Cancer
– ident: e_1_2_4_216_1
  doi: 10.1091/mbc.E06-12-1154
– ident: e_1_2_4_46_1
  doi: 10.1016/j.celrep.2019.02.004
– ident: e_1_2_4_223_1
  doi: 10.1101/gad.197582.112
– volume: 22
  start-page: 2351
  year: 2018
  ident: e_1_2_4_149_1
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– ident: e_1_2_4_229_1
  doi: 10.1038/sj.onc.1204186
– ident: e_1_2_4_250_1
  doi: 10.1016/j.mod.2014.07.001
– ident: e_1_2_4_158_1
  doi: 10.1111/his.12697
– ident: e_1_2_4_190_1
  doi: 10.1002/jcb.26246
– ident: e_1_2_4_261_1
  doi: 10.1038/nrm2890
– year: 2019
  ident: e_1_2_4_103_1
  publication-title: Cells
– ident: e_1_2_4_86_1
  doi: 10.1038/onc.2016.288
– ident: e_1_2_4_210_1
  publication-title: J Cell Sci.
– ident: e_1_2_4_142_1
  doi: 10.3892/or.2017.5642
– ident: e_1_2_4_156_1
  doi: 10.1177/039463201302600115
– ident: e_1_2_4_35_1
  doi: 10.1042/CS20150385
– ident: e_1_2_4_15_1
  doi: 10.1016/j.devcel.2013.04.021
– ident: e_1_2_4_281_1
  doi: 10.1158/1541-7786.MCR-18-0158
– ident: e_1_2_4_78_1
  doi: 10.1074/jbc.M113.529115
– start-page: 132
  year: 2019
  ident: e_1_2_4_119_1
  publication-title: J. Cell Sci.
– ident: e_1_2_4_183_1
  doi: 10.1083/jcb.201501025
– ident: e_1_2_4_79_1
  doi: 10.1038/nm.2940
– ident: e_1_2_4_106_1
  doi: 10.1002/hep.27992
– ident: e_1_2_4_241_1
  doi: 10.1074/jbc.274.12.8335
– ident: e_1_2_4_152_1
  doi: 10.1111/jcmm.13182
– ident: e_1_2_4_48_1
  doi: 10.1038/ncomms14744
– ident: e_1_2_4_93_1
  doi: 10.1016/j.ccr.2009.09.026
– ident: e_1_2_4_171_1
  doi: 10.1016/j.ydbio.2012.05.008
– ident: e_1_2_4_61_1
  doi: 10.1016/j.stem.2017.11.001
– ident: e_1_2_4_239_1
  doi: 10.1038/sj.onc.1204192
– volume: 9
  start-page: 2145
  year: 1994
  ident: e_1_2_4_3_1
  publication-title: Oncogene
– ident: e_1_2_4_264_1
  doi: 10.1016/S0092-8674(03)00278-2
– ident: e_1_2_4_67_1
  doi: 10.1158/0008-5472.CAN-15-2882
– ident: e_1_2_4_175_1
  doi: 10.1681/ASN.2017121272
– ident: e_1_2_4_285_1
  doi: 10.1016/j.str.2015.09.009
– ident: e_1_2_4_153_1
  doi: 10.18632/oncotarget.8979
– ident: e_1_2_4_45_1
  doi: 10.1038/jid.2012.430
– ident: e_1_2_4_7_1
  doi: 10.1016/j.cell.2005.06.007
– ident: e_1_2_4_166_1
  doi: 10.1126/science.aaa4559
– ident: e_1_2_4_167_1
  doi: 10.1242/dev.159467
– ident: e_1_2_4_1_1
  doi: 10.3390/cancers10040115
– ident: e_1_2_4_56_1
  doi: 10.1158/0008-5472.CAN-14-3396
– ident: e_1_2_4_220_1
  doi: 10.1128/MCB.25.14.5859-5868.2005
– ident: e_1_2_4_58_1
  doi: 10.1002/embj.201386082
– ident: e_1_2_4_87_1
  doi: 10.1016/j.cell.2014.06.003
– ident: e_1_2_4_134_1
  doi: 10.1128/MCB.00102-15
– ident: e_1_2_4_16_1
  doi: 10.1016/j.devcel.2008.01.007
– ident: e_1_2_4_92_1
  doi: 10.1016/j.cell.2007.07.019
– ident: e_1_2_4_100_1
  doi: 10.1101/gad.294348.116
– ident: e_1_2_4_125_1
  doi: 10.1371/journal.pone.0091770
– ident: e_1_2_4_178_1
  doi: 10.1016/j.celrep.2018.09.056
– ident: e_1_2_4_138_1
  doi: 10.1038/onc.2015.219
– ident: e_1_2_4_69_1
  doi: 10.1101/gad.233676.113
– ident: e_1_2_4_96_1
  doi: 10.1073/pnas.0911409107
– ident: e_1_2_4_209_1
  doi: 10.1016/j.cell.2017.10.008
– start-page: 4
  year: 2013
  ident: e_1_2_4_163_1
  publication-title: Nat. Commun.
– ident: e_1_2_4_195_1
  doi: 10.1038/ncb2756
– ident: e_1_2_4_64_1
  doi: 10.1073/pnas.1110428108
– ident: e_1_2_4_2_1
  doi: 10.1016/j.cell.2015.10.044
– ident: e_1_2_4_63_1
  doi: 10.1038/nature11693
– ident: e_1_2_4_5_1
  doi: 10.1093/emboj/19.24.6778
– ident: e_1_2_4_32_1
  doi: 10.1242/dev.102798
– ident: e_1_2_4_276_1
  doi: 10.15252/emmm.201708699
– ident: e_1_2_4_9_1
  doi: 10.1242/dev.045500
– ident: e_1_2_4_215_1
  doi: 10.1091/mbc.E14-07-1223
– ident: e_1_2_4_228_1
  doi: 10.1038/onc.2014.281
– ident: e_1_2_4_246_1
  doi: 10.1073/pnas.222561499
– ident: e_1_2_4_25_1
  doi: 10.1016/j.devcel.2017.08.013
– ident: e_1_2_4_244_1
  doi: 10.1101/sqb.1998.63.643
– ident: e_1_2_4_109_1
  doi: 10.1186/s13046-018-0962-5
– ident: e_1_2_4_114_1
  doi: 10.1016/j.celrep.2019.03.091
– ident: e_1_2_4_233_1
  doi: 10.1074/jbc.M302474200
– ident: e_1_2_4_268_1
  doi: 10.1038/nrc969
– ident: e_1_2_4_110_1
  doi: 10.1038/jid.2013.319
– ident: e_1_2_4_123_1
  doi: 10.3892/ol.2016.4829
– ident: e_1_2_4_174_1
  doi: 10.1016/j.oraloncology.2018.02.014
– ident: e_1_2_4_84_1
  doi: 10.1053/j.gastro.2016.05.006
– ident: e_1_2_4_44_1
  doi: 10.1073/pnas.1019603108
– ident: e_1_2_4_280_1
  doi: 10.1074/jbc.M117.805655
– ident: e_1_2_4_11_1
  doi: 10.1016/j.ceb.2017.10.006
– ident: e_1_2_4_4_1
  doi: 10.1093/emboj/18.9.2551
– ident: e_1_2_4_255_1
  doi: 10.3892/or.2015.4329
– ident: e_1_2_4_36_1
  doi: 10.1172/JCI125014
– ident: e_1_2_4_139_1
  doi: 10.1186/1471-2407-13-349
– ident: e_1_2_4_74_1
  doi: 10.1074/jbc.M900843200
– ident: e_1_2_4_54_1
  doi: 10.1073/pnas.1320383110
– ident: e_1_2_4_251_1
  doi: 10.1093/emboj/17.21.6289
– ident: e_1_2_4_150_1
  doi: 10.18632/oncotarget.12382
– ident: e_1_2_4_259_1
  doi: 10.1101/gad.304501.117
– ident: e_1_2_4_14_1
  doi: 10.1101/gad.1602907
– ident: e_1_2_4_62_1
  doi: 10.1101/gad.264515.115
– ident: e_1_2_4_257_1
  doi: 10.1091/mbc.e06-07-0602
– ident: e_1_2_4_282_1
  doi: 10.1093/carcin/bgn278
– ident: e_1_2_4_112_1
  doi: 10.1158/2326-6066.CIR-17-0320
– ident: e_1_2_4_213_1
  doi: 10.1016/j.cub.2010.02.035
– ident: e_1_2_4_242_1
  doi: 10.1186/1750-2187-2-2
– ident: e_1_2_4_266_1
  doi: 10.1126/science.1141084
– ident: e_1_2_4_40_1
  doi: 10.1038/ncb3216
– ident: e_1_2_4_133_1
  doi: 10.1158/2159-8290.CD-15-0224
– year: 2018
  ident: e_1_2_4_199_1
  publication-title: J. Cell. Sci.
– ident: e_1_2_4_117_1
  doi: 10.1038/s41388-018-0301-5
– ident: e_1_2_4_31_1
  doi: 10.1242/dev.133728
– ident: e_1_2_4_218_1
  doi: 10.1074/jbc.274.51.36734
– ident: e_1_2_4_143_1
  doi: 10.3892/or.2014.3349
– ident: e_1_2_4_202_1
  doi: 10.1074/jbc.M109101200
SSID ssj0009624
Score 2.667168
SecondaryResourceType review_article
Snippet The transcriptional co‐activators YAP (or YAP1) and TAZ (or WWTR1) are frequently activated during the growth and progression of many solid tumors, including...
The transcriptional co-activators YAP (or YAP1) and TAZ (or WWTR1) are frequently activated during the growth and progression of many solid tumors, including...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e1900162
SubjectTerms 1-Phosphatidylinositol 3-kinase
Activation
AKT protein
Brain tumors
Breast
Breast carcinoma
breasts
Cancer
cancer therapy
Cell migration
Cell survival
cell viability
Chemotherapy
drug therapy
Fibroblasts
G protein-coupled receptors
Glioma
Growth factors
Hippo pathway
Immunotherapy
Invasiveness
liver
lungs
Melanoma
Metastases
Metastasis
neoplasm cells
Pancreas
Pancreatic carcinoma
Radiation therapy
radiotherapy
Solid tumors
Stiffening
tissue growth
transcription (genetics)
Transcription factors
Tumors
Upstream
YAP/TAZ
Yes-associated protein
Title YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fbies.201900162
https://www.ncbi.nlm.nih.gov/pubmed/32128850
https://www.proquest.com/docview/2390479902
https://www.proquest.com/docview/2371143985
https://www.proquest.com/docview/2524217375
Volume 42
WOSCitedRecordID wos000528705900011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1521-1878
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0009624
  issn: 0265-9247
  databaseCode: DRFUL
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3PS-QwFA6LruDFXX_urK5EELwYpk2TptnbuDruQWWQUUYvJUkTFNxWpp2F_e_3pZ2pO4gK7qVQ8goheS_v-5rkewjtJ0GkOeWUGJkxwrigRDMVEsUs5DsV66C-Hn19Ji4uktFIDv65xd_oQ7Q_3Hxk1Ou1D3Cly-6TaKj2TJL6q9CAWmARXgzDKPHFGygbPMnuxnVZWyAanADTEDPZxoB257-fT0vPsOY8dK1zT__T__f6M1qZ4k7caxxlFX2w-RpaaipR_llHpze9QXfYu_2Oj8f1SQ1cODyc_CrG-BSIenV3iM9tpQBKlvflIVZ5hi9t6bEnOA2uCjxs1Ak20FX_ZPjjJ5nWWCAGUj0lNshsxjJhqYbJUcIBIIuYUCy2oZEOwt1J6YwBIBfGsYsDzYwRXMbSxlRTG22ihbzI7ReENTCZQDnHqWWwEmSSG5HYUDnOvCwd7SAyG-LUTAXIfR2Mh7SRTqapH5y0HZwOOmjtHxvpjRctd2Yzlk5DEFoj6eXzZQDNe20zBI_fEVG5LSbeRgAfjGTCX7HhftdcRAJsthpvaLsTQeJPEh50EK0n_Y1-pkcA8du3r-_5aBstU8_46yOXO2ihGk_sN_TR_K7uy_Fu7fzwFKNkFy0eX_avzv4CH2EB4g
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1dS-QwFA2Lu-K-7K7fo-4aQfDFMJ00aRrfZnX9wHEYlirqS0nThB3QVmY6gv_em7ZTGRYVln0suYGQ3Jt7Tpqci9Bu6PkJp5wSLVNGGBeUJEx1iGIG8p0KEq98Hn3VE_1-eH0tB_VtQvcWptKHaA7cXGSU-7ULcHcg3X5RDU0claTuLTTAFtiFPzJINc7VKRu86O4GZV1bYBqcANUQU91Gj7Zn-8_mpb_A5ix2LZPP8df_MOxv6EuNPHG3cpVF9MFkS2i-qkX5tIxObrqDdtS9PcBHo_KuBs4tjib3-QifAFUv_uzjC1MoAJPj4XgfqyzFv83YoU9wG1zkOKr0CVbQ5fGv6PCU1FUWiIZkT4nxUpOyVBiawPIoYQGS-UwoFpiOlhYC3kpptQYo1wkCG3gJ01pwGUgT0IQafxXNZXlm1hFOgMt4ylpODYO9IJVci9B0lOXMCdPRFiLTOY51LUHuKmHcxZV4Mo3d5MTN5LTQXmP_UIlvvGq5NV2yuA5CaPWlE9CXHjTvNM0QPu6fiMpMPnE2AhihL0P-hg13_82FL8BmrXKHZjg-pP4w5F4L0XLV3xln_BNAfvO18S-dttHCaXTRi3tn_fNN9Jk6_l9ewNxCc8VoYr6jT_qxGI5HP8pIeAZsGgNF
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9swED5Guo2-dOt-tOm6VYPBXiriyJJl7S1blq40C6Gko9uLkWWJFlq7JE6h__1OtuMSxjYYezQ6GXHS6b6TTt8BvIuDMBVMMGpUxikXktGU6z7V3KK_01EaVM-jv43lZBKfn6tpk03o38LU_BDtgZu3jGq_9gZubzLXu2cNTX0oyfxbaIQtuAtvcF9JpgMbw9PR2fieeTeqKttirCEoBhtyxdwYsN76H9Y90y9wcx29Vu5n9OQ_DPwpbDXYkwzqxbIND2z-DB7V1SjvnsPR98G0Nxv8-ECG8ypbgxSOzJbXxZwcYbBeXhySr7bUCCcXl4tDovOMnNqFx5-4cEhZkFnNUPACzkafZ5--0KbOAjXo7hm1QWYznknLUpwgLR2CspBLzSPbN8qhyTulnDEI5vpR5KIg5cZIVLayEUuZDV9CJy9yuwskxWgm0M4JZjnuBpkSRsa2r53gnpqOdYGudJyYhoTc18K4Smr6ZJZ45SStcrrwvpW_qek3fiu5v5qypDFDbA2Vp9BXATa_bZvRgPytiM5tsfQyEmPCUMXiDzLC35zLUKLMTr0c2uGE6PzjWARdYNWs_2WcyUeE-e3X3r90OoDH0-EoGR9PTl7BJvMHAFUG5j50yvnSvoaH5ra8XMzfNKbwE701BFs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=YAP%2FTAZ%3A+Drivers+of+Tumor+Growth%2C+Metastasis%2C+and+Resistance+to+Therapy&rft.jtitle=BioEssays&rft.au=Thompson%2C+Barry+J&rft.date=2020-05-01&rft.issn=0265-9247&rft.volume=42&rft.issue=5+p.e1900162-&rft_id=info:doi/10.1002%2Fbies.201900162&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0265-9247&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0265-9247&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0265-9247&client=summon